CURRICULUM VITAE. Dallas, Texas 75204

Transcription

1 CURRICULUM VITAE NAME: BUSINESS ADDRESS: HOME ADDRESS: Rachel Tate, DO Arthritis Care and Research Center Baylor Research Institute 9900 N Central Expressway Dallas, Texas (214) Office (214) Cell Rachel.tate@gmail.com 4113 Lafayette Street Dallas, Texas EDUCATION: Franciscan St. James Health, Rheumatology, Olympia Fields, IL 07/ /2014 Fellow PGY5 Ultrasound School of North American Rheumatologists 07/ /2014 Fellow Plaza Medical Center, Rheumatology, Fort Worth, TX 07/ /2013 Fellow PGY4 Plaza Medical Center, Internal Medicine, Fort Worth, TX 07/ /2012 Resident PGY3 Des Peres Hospital, Internal Medicine, Fort Worth, TX 07/ /2011 Resident PGY2, Intern Des Moines, College of Osteopathic Medicine, Des Moines, IA 2009 Doctor of Osteopathic Medicine Indiana, College of Arts and Sciences, Bloomington, IN 2005 BA Biochemistry; Minors in Biology, Spanish, Modern Dance CERTIFICATION AND LICENSURE: Rheumatology, AOBIM Certified 2014 Present RhMSUS, American College of Rheumatology 2014 Present Internal Medicine, AOBIM Board Certified 2012 Present Texas, State Licensure in Internal Medicine 2012 Present Advanced Cardiac Life Support Provider 2007 Present Basic Life Support Certification Provider 1993 Present Pediatric Advanced Life Support Provider Medical License #2679, Texas Present MEDICAL SOCIETIES: Dallas Medical Society Member of the American College of Rheumatology American College of Osteopathic Internists Lupus Foundation of America Arthritis Foundation of North Texas Present Present Present Present Present

2 ACADEMIC AWARDS AND HONORS: Fort Worth Top Doc, Fort Worth Magazine 2016 Medical Honoree, Jingle Bell Run, Arthritis Foundation 2015 Most Outstanding Member, DO Class of 2009, Des Moines 2009 Recipient, Rosemary V. Tanner Scholarship 2005 APPOINTMENTS: Student Representative, Alumni Association Board of Directors, Des Moines Elected Class of 2009 student representative by peers Served as voting member for The College of Osteopathic Medicine Club Representative, Student Government Association, Des Moines Chaired Club Bylaws and Handbook Committees Class President, College of Osteopathic Medicine, Des Moines Elected by peers to serve on the Board of Directors, chair Committees, and represent class 2009 Board President, Indiana Memorial Union Board of Directors, Indiana Served as executive member of the Dean of Students Advisory Board of Directors Chaired weekly Board meetings and led Bylaws Committee ACADEMIC: Director of Fellows Education, Rheumatology Winter Clinical Symposium Present Conference Faculty, Rheumnow.com Present American College of Rheumatology State - of the - Art Clinical Symposium Rheumatology Winter Clinical Symposium Assistant Director of Fellows Education, Rheumatology Winter Clinical Symposium Advances in Dermatology, Medpage Today 11/2017 Step Into the Sunshine Author, Rheum Now 08/2018 The No Show Problem Author, Rheum Now 04/2018 A Rheumatologist s Quality of Life Author, Rheum Now 03/2018 What Does Your Desk Say About You? Author, Rheum Now 10/2017 Step Into the Sunshine Fellow, Ultrasound School of North American Rheumatologists USSONAR accreditation candidate and certificate recipient Instructor Assistant, College of Osteopathic Medicine, Des Moines Osteopathic Manipulative Medicine Physical Diagnosis Medical Spanish

3 ASSIGNMENTS AND DUTIES: Interviewer, College of Osteopathic Medicine, Des Moines Selected by Admissions Office to interview class of 2010 candidates Led new student orientation and campus tours ADVISORY AND CONSULTANT FOR: 1. AbbVie Inc. 2. Horizon Pharmaceuticals 3. Lilly NATIONAL SPEAKERS BUREAU: 1. AbbVie Inc. 2. Amgen COMMUNITY/CIVIC ACTIVITIES: Crohn s and Colitis Foundation of America 2017 Present Member and Fundraiser for Spin4 Facebook: Physician Mom s Group (PMG) 2016 Present Member and contributor with over 71,000 members Facebook: Women s Rheumatology Group 2016 Present Member and contributor with over 700 members Habitat for Humanity 2017 Present Dallas area construction volunteer Crohn s and Colitis Foundation 2017 Present Participant and volunteer for annual events Lupus Foundation of America 2001 Present Participant, volunteer, and fund raiser for annual events (Lotus 4 Lupus, Walk for Lupus Now, and Advocacy Day) Arthritis Foundation Present Participant and volunteer for annual events including Jingle Bell Run, Arthritis Walk, and Joints in Motion, to raise money for Rheumatoid Arthritis and JIA research. Osteopathic Finish Line Treated patients using Osteopathic Manipulative Medicine Instructed patients about Osteopathy and Osteopathic Manipulative Medicine La Clinica Local facility clinical volunteer serving the Des Moines Hispanic population Geriatrics Health Fair Conducted health screens of the geriatric population of Des Moines What s in a Doctor s Bag? Volunteer at Des Moines area schools lecturing about health Care provider careers COMMITTEES AND ADMINISTRATION: Member, Steering Committee, Crohn s and Colitis Foundation of America Spin4Colitis, Dallas event scheduled for 10/14/ present

4 Member, Press Ganey Committee, USMD Specialty representative for implementation of Press Ganey at USMD Member, Stroke Accreditation Committee, Des Peres Hospital House staff, resident representative PRESENTATIONS: Regional /National Invites: RWCS Day 3 Podcast/Video 02/2018 ACR Day 4 Podcast/Video 11/2017 ACR Day 3 Podcast/Video 11/2017 ACR Day 2 Podcast/Video 11/2017 ACR Day 1 Podcast/Video 11/2017 ACR Day 4 Video 10/2016 ACR Day 3 Video 10/2016 ACR Day 2 Video 10/2016 ACR Day 1 Video 10/2016 Clinical Investigator, ACR Abstract #355 11/2017 Poster presentation entitled: Perceptions and Outcomes of Pregnancy and Lactation in Patients with Rheumatic Diseases Clinical Investigator, Baylor Scott and White Health Research Day 04/2017 Poster presentation entitled: Perceptions and Outcomes of Pregnancy and Lactation in Patients with Rheumatic Diseases Clinical Research Presenter, Rheumatology Winter Symposium 02/2014 Poster presentation entitled: An Atypical Presentation of Susac Syndrome Presentations: Live Your Yes! 09/2018 Arthritis Foundation of North Texas Rheumatoid Arthritis 10/2015 Arthritis Foundation of North Texas Board Review - Key Topics in Rheumatology 06/2014 Rheumatology Emergencies 05/2014 Antibodies and Immunology 3 04/2014 Midwestern Antibodies and Immunology 2 03/2014 Midwestern Antibodies and Immunology 1 01/2014 Midwestern Scleroderma and Mimics 01/2014

5 MSKUS and the Rheumatologist 12/2013 Osteoporosis Guidelines and Treatments 11/2013 An Atypical Presentation of Susac Syndrome 11/2013 of Chicago An Atypical Presentation of Susac Syndrome 10/2013 The Biologic Era: A Mechanism of Action Review 10/2013 Leflunomide 09/2013 Mycophenolate 09/2013 Plaquenil 09/2013 Azathioprine 08/2013 Methotrexate and You 07/2013 The Rituxan Conundrum 07/2013 Treatment of Hepatitis C Manifestations 05/2013 of North Texas Health Science Center A Case of Cryoglobulinemia Vasculitis 04/2013 of North Texas Health Science Center OA vs RA: The Synovial Plot Thickens 03/2013 Plaza Medical Center of Fort Worth A Case of RA: What an Internist Needs To Know 02/2013 Plaza Medical Center of Forth Worth Fourth Year Medical Student Review of Rheumatology 01/2013 of North Texas Health Science Center Crystalline Arthropathy 11/2012 Plaza Medical Center of Fort Worth Sjogren's Syndrome Manifestations: Not Just Sicca 10/2012 Plaza Medical Center of Fort Worth

6 CLINICAL RESEARCH: Principle Investigator: Randomized, Double - Blind, Active Control Multicenter Study 02/ Present to Evaluate the Efficacy at Week 52 of Subcutaneously Administered Adalimumab versus Secukinumab Monotherapy in Patients with Active Psoriatic Arthritis. Associate Investigator: Treatments Against RA and Effect of FDG PET- SCT 05/ Present A Prospective observational cohort of patients with moderate 04/ Present -to- severe SLE to characterize cross-sections and longitudinal disease activity, treatment patterns and effectiveness, healthcare resource utilizations, and the impact of SLE on quality of life Randomized, Double Blind, Placebo Controlled, Multicenter, 02/ Present Phase III Efficacy and Safety Study of Subcutaneous Anakinra in Patient s with Still s Disease Phase II Randomized, Double Blind, Placebo Controlled Study 02/ Present To Evaluate Safety and Efficacy of BMS in Participants with Systemic Lupus Erythematosus Prospective Observational Cohort of Patients 02/ Present with Moderate to Severe SLE to Characterize Cross Sectional and Longitudinal Disease Activity, Treatment Patterns and Effectiveness, Outcomes and Comorbidities, Healthcare Resource Utilization, and the Impact of SLE on Quality of Life A Randomized, Controlled, Double-Blind, Study 12/ Present Comparing the Efficacy and Safety of Voclosporin with Placebo in Achieving Renal Response in Subjects with Active Lupus Nephritis A Randomized, Double Blind, Placebo Controlled, 08/ Present Parallel Group, Multicenter Study to Evaluate the Safety and Efficacy of Secukinumab 300mg and 150mg in Adult Patients with Active Psoriatic Arthritis after 16 weeks of Treatment Comparted to Placebo and to Assess the Safety, Tolerability, and Efficacy up to 52 Weeks A Phase II, Two Stage, Randomized, Double Blind, 05/ Present Double Dummy, Parallel Group Study of the Efficacy and Safety of GDC 0853 in Combination with Background Methotrexate in Patients with Active Rheumatoid Arthritis and an Inadequate Response to Previous Methotrexate A Phase II, Two Stage, Randomized, Double Blind, 05/ Present Double Dummy, Parallel Group Study of the Efficacy and Safety of GDC 0853 in Combination with Background Methotrexate in Patients with Active Rheumatoid Arthritis and an Inadequate Response to 1 or 2 TNF Inhibitors and Methotrexate A Phase III, Randomized, Double-Blind Study 02/2017 Present Comparing ABT 494 to Placebo on Stable Conventional Synthetic Disease with Modifying anti Rheumatic Drugs (csdmards) in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intolerance to Biologic DMARDs

7 A Phase III, Randomized, Double-Blind Study 02/2017 Present Comparing ABT 494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Are on a Stable Dose of Conventional Synthetic Disease Modifying Anti Rheumatic Drugs Perceptions and Outcomes of Pregnancy and Lactation in Patients with Rheumatic Diseases 09/ Present A Multi-center, Randomized, Double Blind, 11/ /2018 Placebo controlled Phase III Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematous A Phase III, Randomized, Double Blind, Placebo Controlled Study 02/ /2018 to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain and Osteoarthritis of the Hip and Knee A Multicenter, Parallel Group Study of Long Term 09/ /2018 Safety and Efficacy of CNTO136 (Sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 and CNTO136ARA3003 A Phase IIIb/IV Randomized Safety Endpoint Study 09/ /2017 of 2 doses of Tofacitinib in Comparison to a Tumor Necrosis Factor Inhibitor in Subjects with Rheumatoid Arthritis